JW Pharmaceutical Corp (001065) — Financial Flexibility Index
JW Pharmaceutical Corp (001065) has a Financial Flexibility Index of 0.22x as of September 2025. Free cash flow of ₩56.71 Billion (operating CF ₩46.92 Billion minus capex ₩9.80 Billion) represents 0% of total liabilities (₩257.46 Billion). Check JW Pharmaceutical Corp (001065) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
JW Pharmaceutical Corp Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for JW Pharmaceutical Corp across 11 annual periods. See 001065 working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for JW Pharmaceutical Corp (2014–2024)
Year-by-year free cash flow to debt coverage for JW Pharmaceutical Corp. For the full company profile including market capitalisation, see market cap of JW Pharmaceutical Corp.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.39x | ₩107.53 Billion | ₩79.39 Billion | ₩275.11 Billion | ▲ +16.0% |
| 2023 | 0.34x | ₩127.86 Billion | ₩87.16 Billion | ₩379.60 Billion | ▲ +103.2% |
| 2022 | 0.17x | ₩66.68 Billion | ₩56.76 Billion | ₩402.21 Billion | ▲ +188.0% |
| 2021 | 0.06x | ₩25.59 Billion | ₩18.12 Billion | ₩444.51 Billion | ▼ -73.9% |
| 2020 | 0.22x | ₩75.44 Billion | ₩63.05 Billion | ₩341.62 Billion | ▲ +16.9% |
| 2019 | 0.19x | ₩64.82 Billion | ₩55.53 Billion | ₩343.12 Billion | ▲ +3.8% |
| 2018 | 0.18x | ₩60.75 Billion | ₩52.11 Billion | ₩333.68 Billion | ▲ +60.1% |
| 2017 | 0.11x | ₩40.95 Billion | ₩33.45 Billion | ₩360.10 Billion | ▲ +154.3% |
| 2016 | 0.04x | ₩16.76 Billion | ₩6.74 Billion | ₩374.76 Billion | ▲ +1156.3% |
| 2015 | 0.00x | ₩1.38 Billion | ₩-4.17 Billion | ₩388.07 Billion | ▼ -90.7% |
| 2014 | 0.04x | ₩14.21 Billion | ₩7.28 Billion | ₩369.22 Billion | — |